Percutaneous biopsy for risk stratification of renal masses

by Michael L. Blute, Anna Drewry, Edwin Jason Abel
Published 2015-10-01

Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer

by Nathan A. Damaschke, Bing Yang, Michael L. Blute, Jr., Chee Paul Lin, Wei Huang, David F. Jarrard
Published 2014-12-01

Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐anal...

by Yu Zheng, Sharron X. Lin, Shulin Wu, Douglas M. Dahl, Michael L. Blute, Wei‐De Zhong, Xing Zhou, Chin‐Lee Wu
Published 2020-09-01

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy.

by Michael L Blute, Nathan Damaschke, Jennifer Wagner, Bing Yang, Martin Gleave, Ladan Fazli, Fangfang Shi, E Jason Abel, Tracy M Downs, Wei Huang, David F Jarrard
Published 2017-01-01